ITG and Adicet Bio Shares Plunge Amid Sharp Profit-Taking Reversal

Key Facts

1ITG shares fell 32.59% to $7.07 despite the company reporting strong Q2 results.

2Adicet Bio shares dropped 29.60% following positive Phase 1 clinical data.

3Jaguar Health declined 21.82% and Ocular Therapeutix fell 20.67% on heavy trading volume.

ITG shares fell 32.59% to $7.07 despite the company reporting strong Q2 results, according to Financial Modeling Prep. Other significant decliners included Adicet Bio, which dropped 29.60% following positive Phase 1 clinical data, while Jaguar Health declined 21.82% and Ocular Therapeutix fell 20.67% on heavy trading volume.

ITG closed at $10.48 on September 25, 2026, and ACET closed at $9.02 on the same date prior to the recent pullback. On September 28, 2026, GRML closed at $12.2895 and JAGX closed at $5.95, with the declines appearing to be technical in nature as investors engaged in profit-taking and risk-off positioning following recent corporate updates.